Cytodyn

CytoDyn is a biotechnology company focused on the development of new therapiesto combat infections with immune deficiency viruses.

Raised

$37.6M

Follow us

Also headquartered in Vancouver

Companies in the same industry

Alexa global traffic share

Twitter followers

Built with ❤︎ by Datalicious ©2020
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Add info

Add round

11 May 2016

$4,300,000

Venture capital

23 Feb 2016

$33,270,000

Post-IPO equity